INDOCO

INDOCO REMEDIES

Small Cap BSE: 532612 NSE: INDOCO
₹321.65
10 (3.21%)
As on 30 September, 2022 | 02:39

Indoco Remedies Share Price

Indoco Remedies Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in INDOCO REMEDIES

Start SIP

Indoco Remedies Share Returns

  • Over 1 Month -10.04%
  • Over 3 Month -13.01%
  • Over 6 Month -12.07%
  • Over 1 Year -27.66%

Indoco Remedies Key Statistics

P/E Ratio 19.3
PEG Ratio 0.6
Market Cap Cr 2,964
Price to Book Ratio 3.3
EPS 16.8
Dividend 0.7
Relative Strength Index 31.17
Money Flow Index 4.24
MACD Signal -7.89
Average True Range 13.82

Indoco Remedies Investment Rating

  • Master Rating:
  • Indoco Remedies has an operating revenue of Rs. 1,562.22 Cr. on a trailing 12-month basis. An annual revenue growth of 24% is outstanding, Pre-tax margin of 15% is great, ROE of 17% is exceptional. The company has a reasonable debt to equity of 11%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 94 which is a GREAT score indicating consistency in earnings, a RS Rating of 10 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 125 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Indoco Remedies Financials
IndicatorJun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 395400358387386295
Operating Expenses Qtr Cr 337328284300300250
Operating Profit Qtr Cr 718073868755
Depreciation Qtr Cr 201819192219
Interest Qtr Cr 434345
Tax Qtr Cr 10191823229
Net Profit Qtr Cr 384033424025

Indoco Remedies Technicals

EMA & SMA

Current Price
321.65
10 (3.21%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 345.27
  • 50 Day
  • 358.11
  • 100 Day
  • 366.96
  • 200 Day
  • 380.56
  • 20 Day
  • 351.64
  • 50 Day
  • 365.34
  • 100 Day
  • 364.99
  • 200 Day
  • 380.61

Indoco Remedies Resistance and Support

PIVOT
₹318.2
Resistance
First Resistance 328.25
Second Resistance 344.85
Third Resistance 354.9
RSI 31.17
MFI 4.24
MACD Single Line -7.89
MACD -11.77
Support
First Resistance 301.61
Second Resistance 291.55
Third Resistance 274.95

Indoco Remedies Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 246,679 13,838,692 56.1
Week 215,771 9,442,148 43.76
1 Month 111,449 5,144,486 46.16
6 Month 106,094 5,161,469 48.65

Indoco Remedies Result Highlights

Indoco Remedies Synopsis

NSE-Medical-Diversified

Indoco Remedies is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1539.72 Cr. and Equity Capital is Rs. 18.43 Cr. for the Year ended 31/03/2022. Indoco Remedies Ltd. is a Public Limited Listed company incorporated on 23/08/1947 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L85190MH1947PLC005913 and registration number is 005913.
Market Cap 2,964
Sales 1,561
Shares in Float 3.78
No of funds 61
Yield 0.47
Book Value 3.28
U/D Vol ratio 1.1
LTDebt / Equity 11
Alpha -0.11
Beta 0.61

Indoco Remedies

Owner NameJun-22Mar-22Dec-21Sep-21
Promoters 58.69%58.69%58.69%
Mutual Funds 17.39%17.52%17.1%
Insurance Companies 0.13%0.13%0.13%
Foreign Portfolio Investors 1.17%1.15%1.62%
Individual Investors 17.22%17.87%17.87%
Others 5.4%4.64%4.59%

Indoco Remedies Management

Name Designation
Mr. Suresh G Kare Chairman
Ms. Aditi Panandikar Managing Director
Mr. Sundeep V Bambolkar Joint Managing Director
Dr. Anand Nadkarni Non Executive Director
Mr. D M Gavaskar Independent Director
Mr. Rajiv P Kakodkar Independent Director
Dr.(Ms.) Vasudha V Kamat Independent Director
Mr. Abhijit Y Gore Independent Director

Indoco Remedies Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Indoco Remedies Corporate Action

Date Purpose Remarks
2022-08-09 Quarterly Results
2022-05-17 Audited Results & Final Dividend
2022-02-01 Quarterly Results
2021-11-02 Quarterly Results
2021-08-11 Quarterly Results

Indoco Remedies MF Shareholding

Name Amount(cr)
Nippon India Small Cap Fund - Growth 21655
Franklin India Smaller Companies Fund Growth 7033
HDFC Capital Builder Value Fund Growth 5418
Nippon India Pharma Fund - Growth 4588
ICICI Prudential Smallcap Fund Growth 4138

Indoco Remedies FAQs

What is Share Price of Indoco Remedies ?

Indoco Remedies share price is ₹321 As on 30 September, 2022 | 02:25

What is the Market Cap of Indoco Remedies ?

The Market Cap of Indoco Remedies is ₹2964 Cr As on 30 September, 2022 | 02:25

What is the P/E ratio of Indoco Remedies ?

The P/E ratio of Indoco Remedies is 19.3 As on 30 September, 2022 | 02:25

What is the PB ratio of Indoco Remedies ?

The PB ratio of Indoco Remedies is 3.3 As on 30 September, 2022 | 02:25

Q1FY23